Protective Effects of 20(S)-Protopanaxtriol on Viral Myocarditis Infected by Coxsackievirus B3 | |
Wang, Xiaoyan1; Wang, Yafeng1; Ren, Zhe1; Qian, Chuiwen1; Li, Yicheng1; Wang, Qingduan2; Zhang, Yan2; Zheng, Liyun2; Jiang, Jinhua2; Yang, Chongren3; Wang, Dong2![]() ![]() | |
2012 | |
发表期刊 | PATHOBIOLOGY
![]() |
卷号 | 79期号:6页码:285-289 |
摘要 | Objective: Coxsackievirus B3 (CVB3) is a dominant causative agent for viral myocarditis. So far, effective therapies for the treatment of the disease are not available. 20(S)-Protopanaxtriol is a major component of Panax pseudoginseng and has been clinically used for the treatment of heart diseases. However, it is not known whether 20(S)-protopanaxtriol exerts any anti-viral effects. Thus, the aim of this study was to investigate the therapeutic effects of 20(S)-protopanaxtriol against CVB3 in vivo and in vitro. Methods: The antiviral effects of 20(S)-protopanaxtriol in vitro were evaluated in HeLa cells infected by CVB3. Then, we examined the protective effects of 20(S)-protopanaxtriol on CVB3-induced myocarditis in BALB/c mice. These mice were treated with 20(S)-protopanaxtriol at doses of 100-400 mg.kg(-1).day(-1) for 7 days and compared with the controls. Results: We found that 20(S)-protopanaxtriol possessed potent antiviral effects on CVB3 in vitro. Compared with control mice, virus titers and pathological changes in the hearts were significantly decreased in the 20(S)-protopanaxtriol-treated group. Furthermore, biochemical markers of myocardial injury such as plasma lactate dehydrogenase and creatine kinase were decreased to normal levels. Conclusions: These data provide the possibility that 20(S)-protopanaxtriol can be used as a potential therapeutic means for treatment of viral myocarditis. Copyright (c) 2012 S. Karger AG, Basel |
关键词 | Myocarditis 20(s)-protopanaxtriol Coxsackievirus B3 |
DOI | 10.1159/000331229 |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000305192800001 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.kib.ac.cn/handle/151853/20434 |
专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
作者单位 | 1.Jinan Univ, Natl Engn Res Ctr Genet Med, Guangzhou 510630, Guangdong, Peoples R China 2.Henan Inst Med Sci, Zhengzhou, Peoples R China 3.Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China 4.Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Tamaho, Yamanashi, Japan |
推荐引用方式 GB/T 7714 | Wang, Xiaoyan,Wang, Yafeng,Ren, Zhe,et al. Protective Effects of 20(S)-Protopanaxtriol on Viral Myocarditis Infected by Coxsackievirus B3[J]. PATHOBIOLOGY,2012,79(6):285-289. |
APA | Wang, Xiaoyan.,Wang, Yafeng.,Ren, Zhe.,Qian, Chuiwen.,Li, Yicheng.,...&Wang, Yifei.(2012).Protective Effects of 20(S)-Protopanaxtriol on Viral Myocarditis Infected by Coxsackievirus B3.PATHOBIOLOGY,79(6),285-289. |
MLA | Wang, Xiaoyan,et al."Protective Effects of 20(S)-Protopanaxtriol on Viral Myocarditis Infected by Coxsackievirus B3".PATHOBIOLOGY 79.6(2012):285-289. |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
wang2012.pdf(749KB) | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | 浏览 下载 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论